Epitope mapping of new monoclonal antibodies recognizing distinct human FcRII (CD32) isoforms

Hybridoma

Volumn 15, Issue 2, 1996, Pages 109-116

  Weinrich, Volker ^a   Sondermann, Peter ^a   Bewarder, Nils ^a   Wissel, Kirsten ^a   Frey, Jürgen ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; FC RECEPTOR; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0029968319     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.109     Document Type: Article

References (35)

1. Ravetch JV: Fc receptors: Rubor redux. Cell 1994;78:553-560.
2. Van de Winkel JGJ, and Capel PJA: Human IgG Fc receptor heterogeneity: Molecular aspects and clinical implications. Immunol Today 1993;14:215-221.
3. Brooks DG, Qiu WQ, Luster AD, and Ravetch JV: Structure and expression of human IgG FcRII (CD32). J Exp Med 1989; 170:1369-1385.
4. Warmerdam PAM, Nabben NMJM, van de Graaf SAR, van de Winkel JGJ, and Capel PJA: The human low-affinity immunoglobulin G Fc receptor IIC is a result of an unequal crossover event. J Biol Chem 1993;268:7346-7349.
5. Warmerdam PAM, van de Winkel JGJ, Gosselin EJ, and Capel PJA: Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med 1990;172:19-25.
6. Looney RJ, Abraham GN, and Anderson DL: Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J Immunol 1986;136:1641-1647.
7. Zipf TF, Lauzon GJ, and Longenecker BM: A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukaemia cells, but is rare on acute lymphocytic leukaemia blasts. J Immunol 1983;131: 3064-3072.
8. Pulford K, Ralfkiaer E, Macdonald SM, Erber WN, Falini B, Gatter KC, and Mason DY: A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. Immunology 1986;57:71-76.
9. Greenman J, Tutt AL, George AJT, Pulford KAF, Stevenson GT, and Glennie MJ: Characterization of a new monoclonal anti-FcγRII antibody, AT10, and its incorporation into bispecific F(ab′)2 derivative for recruitment of cytotoxic effectors. Mol Immunol 1991;28:1243-1254.
10. Ierino FL, Hulett MD, McKenzie FC, and Hogarth PM: Mapping epitopes of human FcγRII (CDw32) with monoclonal antibodies and recombinant receptors. J Immunol 1993;150:1794-1803.
11. Micklem KJ, Stross WP, Willis AC, Cordell JL, Jones M, and Mason DY: Different isoforms of human FcRII distinguished by CDw32 antibodies. J Immunol 1990;144:2295-2303.
12. Budde P, Weinrich V, Sondermann P, Bewarder N, Kilian A, Schulzeck O, and Frey J: Leukocyte Typing V. Specificity of CD32 mAbs for FcRIIa, FcRIIb1 and FcRIIb2 expressed in transfected mouse B cells and BHK-21 cells. In: Myeloid Antigen. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, and Todd RF (Eds). Oxford University Press, Oxford, 1995, pp. 828-832.
13. Engelhardt W, Geerds C, and Frey J: Distribution, inducibility, and biological function of the cloned and expressed human βFc receptor II. Eur J Immunol 1990;20:1367-1377.
14. Stengelin S, Stamenkovic I, and Seed B: Isolation of cDNAs for two distinct Fc receptors by ligand affinity cloning. EMBO J 1988;7:1053.
15. Gieffers C, and Krohne G: In vitro reconstitution of recombinant lamin A and a lamin A mutant lacking the carboxy-terminal tail. Eur J Cell Biol 1991;55:191-199.
16. Hochuli E, Döbeli H, and Schacher A: New meal chelate adsorbents selective for proteins and peptide containing neighbouring histidine residues. J Chromatogr 1987;411:177-184.
17. Weigand K, Birr C, and Suter M: The hexa- and pentapeptide extension of Proalbumin. Biochim Biophys Acta 1981;670:424-427.
18. Prass W, Ringsdorf H, Bessler W, Wiesmüller K, and Jung G: Lipopeptides of the N-terminus of E. coli lipoprotein: Synthesis, mitogenicity and properties in monolayer experiments. Biochim Biophys Acta 1987;900:116-128.
19. Wiesmüller K, Jung G, Gillessen D, Loffel C, Bessler WG, and Böltz T: The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Immunology 1991;72:109-113.
20. Fazekas de St. Groth S, and Scheideger D: Production of monoclonal antibodies: Strategy and tactic. J Immunol Methods 1980;35:1-24.
21. Bonnerot C, Amigorena S, Choquet D, Pavlovich R, Chokrann V, and Fridman WH: Role of associated γ-chain in tyrosine kinase activation via murine FcγRIII. EMBO J 1992;11:2747-2757.
22. Engelhardt W, Gorczytza H, Butterweck A, Mönkemann H, and Frey J: Structural requirements of the cytoplasmic domains of the human macrophage Fcγ receptor IIa and B cell receptor IIb2 for the endocytosis of immune complexes. Eur J Immunol 1991;21:2227-2238.
23. Budde P, Bewarder N, Weinrich V, and Frey J: Biological functions of human Fcγ RIIa/FcγRIIc in B cells. Eur J Cell Biol 1994;64:45-60.
24. Budde P, Bewarder N, Weinrich V, Schulzeck O, and Frey J: Tyrosine-containing sequence motif of the human immunoblobin G receptor FcRIIb1 and FcRIIb2 essential for endocytosis and regulation of calcium flux in B cells. J Biol Chem 1994;269: 30636-30644.
25. Shore A, Dosch HM, and Gelfand EW: Induction and separation of antigen-dependent T helper and T suppressor cells in man. Nature (London) 1978;274:586-587.
26. Thiele DL, and Lipssky PE: Modulation of human natural killer cells function by 1-leucin methyl ester: Monocyte-dependent from human peripheral blood mononuclear cells. J Immunol 1985; 134:786-793.
27. Huang M.-M., Indik Z., Brass LF, Hoxie JA, Schreiber AD, and Brugge JS: Activation Fcγ RII induces tyrosine phosphorylation of multiple proteins including FcγRII. J Biol Chem 1992;267:5467-5473.
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970;227: 680-685.
29. Sanger F, Nicklen S, and Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463.
30. Frank R: Spot-synthesis: An easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 1992;48:9217-9232.
31. Grosjean H, and Fiers W: Preferential codon usage in prokaryotic genes: The optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. Gene 1982;18: 199-209.
32. Cassel DL, Keller MA, Surrey S, Schreiber AD, Rappaport EF, and McKenzie SE: Differential expression of FcγRIIA, FcγRIIB, FcγRIIC in hematopoietic cells: Analysis of transcripts. Mol Immunol 1993;30:451-460.
33. Mantzioris BX, Berger MF, Sewell W, and Zola H: Expression of Fc receptor for IgG (FcγRII/CDw32) by human circulating T and B lymphocytes.; Immunol 1993;150:5175-5184.
34. Van den Herik-Oudijk I, Westerdaal NAC, Henriquez NV, Capel PJA, and van de Winkel JGJ: Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes. J Immunol 1994;152:574-585.
35. Gergely J, Rozsnyay Z, and Sarmay G: New aspects of FcγRII-mediated B-cell inhibition: Switch of FcγRII isoforms depends on B-cell activation. Immunologist 1994;2:77-81.